Healthix Inc

THE MISSION OF THE COMPANY IS TO CREATE AN ACHIEVABLE, SUSTAINABLE AND REPLICABLE MODEL FOR INTEGRATING CLINICAL INFORMATION ACROSS MULTIPLE HEALTH CARE ORGANIZATIONS WHICH SUPPORTS NEW YORK STATE AND FEDERAL STRATEGIC HEALTH INFORMATION TECHNOLOGY (HIT) PLANS TO (A) IMPROVE ACCESS TO PATIENT DATA AT THE POINT OF CARE; (B) IMPROVE HEALTH CARE QUALITY; AND (C) REDUCE INAPPROPRIATE UTILIZATION AND COST.

SHIN-NY GRANT/HCRA/MEDICAID PROGRAMPROGRAM DESCRIPTIONHEALTHIX WORKS WITH OUR PARTICIPANTS TO INTEGRATE THEM INTO THE HIE AND TO WORK WITH THEM TO DESIGN AND DEVELOP PRODUCTS AND SERVICES THAT HELP THEM TO IMPROVE CARE THROUGH BETTER CARE COORDINATION. IN 2021 WE USED THE FUNDING FROM SHIN-NY/HCRA/MEDICAID TO SUPPORT BUSINESS DEVELOPMENT, COMPLIANCE, RELATIONSHIP MANAGEMENT, PROJECT MANAGEMENT, DEVELOPMENT, ENGINEERING, QUALITY ASSURANCE AND SUPPORT. OUR BUSINESS DEVELOPMENT TEAM RECRUITS NEW PARTICIPANTS, ENSURES COMPLIANCE WITH STATE PRIVACY & SECURITY POLICIES AND PREPARES STATEMENTS OF WORK TO HAND OFF TO THE PROJECT MANAGEMENT, CUSTOMER EXPERIENCE AND DEVELOPMENT & ENGINEERING TEAMS.BUSINESS DEVELOPMENT TEAM IS COMPRISED OF A VICE PRESIDENT OF OPERATIONS & BUSINESS DEVELOPMENT AND TWO BUSINESS DEVELOPMENT PARTNERS. THE COMPLIANCE DEPARTMENT IS COMPRISED OF SR DIRECTOR OF COMPLIANCE AND FOUR COMPLIANCE PARTNERS. THE PROJECT MANAGEMENT OFFICE IS COMPRISED OF THE ASSISTANCE VICE PRESIDENT, TEAM LEAD, THREE SENIOR PROJECT MANAGERS AND THREE PROJECT MANAGERS. THE CUSTOMER EXPERIENCE TEAM IS COMPRISED OF A DIRECTOR AND SEVEN RELATIONSHIP MANAGERS. THE DEVELOPMENT TEAM IS COMPRISED OF SIX INTEGRATION ENGINEERS AND THE ENGINEERING TEAM IS COMPRISED OF FOUR NETWORK ENGINEERS AND AN ENGINEERING MANAGER. DEVELOPMENT AND ENGINEERING TEAMS ARE PART OF THE INFORMATION TECHNOLOGY DEPARTMENT LED BY OUR CHIEF INFORMATION OFFICER WHO ALSO MANAGES THE INFORMATION SECURITY GROUP COMPRISED OF A CHIEF INFORMATION SECURITY OFFICER AND TWO INFORMATION SECURITY ANALYSTS. THE IT DEPARTMENT IS AUGMENTED BY TWO TO THREE CONTRACT DEVELOPERS. IN ADDITION, THE FUNDING SUPPORTED OFFICE SPACE AND DATA CENTER OPERATIONS.ACCOMPLISHMENTSIN 2021 HEALTHIX COMPLETED 682 PROJECTS INCLUDING 536 CUSTOMER PROJECTS, 37 INTERNAL PROJECTS, 23 VENDOR DEVELOPMENT PROJECTS, 7 PRODUCT DEVELOPMENT PROJECTS, 16 GRANTS PROJECTS, 50 PUBLIC HEALTH PROJECTS AND 8 PROJECTS WITH BUSINESS PARTNERS. THE 536 CUSTOMER PROJECTS INCLUDED CONNECTING NEW PARTICIPANTS TO HEALTHIX AND PROVIDING THEM WITH STANDARD AND CUSTOM SERVICES.HEALTHIX CUSTOMER PROJECTS IN 2021 WERE WITH THE FOLLOWING TYPES OF FACILITIES:FACILITY TYPE (RECORD COUNT)AMBULATORY (406)HEALTH SYSTEMS AND HOSPITALS (66)UNCLASSIFIED (56)LABORATORY/RADIOLOGY (39)BEHAVIORAL HEALTH ORGANIZATIONS (23)LONG TERM CARE/SKILLED NURSING FACILITY (21)EMERGENCY MEDICAL SERVICES (18)FEDERALLY QUALIFIED HEALTH CENTERS (12)HEALTH PLANS (10)NYC AND NYS PUBLIC HEALTH ORGANIZATIONS (8)HOME CARE (7)DURING THE YEAR ENDED DECEMBER 31, 2021, THE COMPANY RECORDED $19,113,308 IN REVENUE IN CONNECTION WITH THIS PROGRAM.1. THE ILUM/NY-LEADS PROJECT YEAR 2OBJECTIVES OF THE NYSDOH LEADS SYSTEMTHE THREAT OF ANTIMICROBIAL RESISTANCE (AR) CONTINUES TO GROW. THE CDC ESTIMATES THAT AT LEAST TWO MILLION PEOPLE BECOME INFECTED WITH ANTIBIOTIC RESISTANT BACTERIA AND AT LEAST 23,000 PEOPLE DIE EACH YEAR AS A DIRECT RESULT OF THESE INFECTIONS WITHIN THE UNITED STATES. IN AN EFFORT TO ADDRESS THIS EMERGING PUBLIC HEALTH NEED, NEW YORK STATE DEPARTMENT OF HEALTH LABORATORY, EPIDEMIOLOGY, DIGITAL TEAM ("NYS-DOH") AND ILUM HEALTH SOLUTIONS, LLC ("ILUM") WORKED COLLABORATIVELY TO BUILD A SUSTAINABLE, FLEXIBLE INFECTIOUS DISEASES REPORTING, TRACKING AND SURVEILLANCE TOOL FOR AR THAT CAN BE APPLIED ACROSS NEW YORK STATE. THE GOAL OF THIS PROJECT WAS TO IMPROVE PATIENT OUTCOMES AND SAVE HEALTH CARE DOLLARS BY INTEGRATING REAL TIME EPIDEMIOLOGIC SURVEILLANCE WITH RAPID DELIVERY OF RESULTS TO CARE GIVERS VIA WEB-BASED AND MOBILE PLATFORMS.GOALTHE GOAL OF THIS PROJECT WAS TO ASSESS WHETHER TO DEPLOY A RAPID STATE-WIDE ALERT SYSTEM TO NOTIFY HEALTH CARE FACILITIES OF PATIENTS WITH ANTIMICROBIAL RESISTANT INFECTIONS AS THEY MOVE FROM FACILITY TO FACILITY AND TO ASSESS A RAPID DIAGNOSTIC PLATFORM TO DETERMINE A PATIENT'S GENOMIC PROFILE AND ANTIBIOGRAM TO ALLOW TARGETED INFECTION CONTROL AND TREATMENT.THE PROJECT COMMENCED IN 2019 AS A SMALL-SCALE DEMONSTRATION PROJECT THAT INCLUDED PILOTS WITH NYU LANGONE MEDICAL CENTER AND NORTHWELL HEALTH. YEAR 1 ENDED IN MARCH OF 2020 AND YEAR 2 COMMENCED IN APRIL OF 2020. IN YEAR 2 WE ADDED SOUTHAMPTON, STONY BROOK, MEDISYS AND CATHOLIC HEALTH SERVICES OF LONG ISLAND COMPRISING A TOTAL OF NINE ADDITIONAL HOSPITALS.DESCRIPTIONBELOW IS A DESCRIPTION OF THE MILESTONES OF THE PROGRAM MET IN 2021: I. DATA GAP ANALYSIS AND REVIEW GROUP 2 HOSPITALS 1. HEALTHIX AND NYSTEC WILL COLLABORATIVELY REVIEW THE LIST OF FIRST 3 FACILITIES IN SCOPE FROM THE CONTRACT AND ANALYZE THEIR MICROBIOLOGY DATA FOR COMPLIANCE WITH THE LIST OF LOINC AND SNOMED CODES PROVIDED BY DOH. THE TEAM WILL ALSO ANALYZE FOR COMPLIANCE WITH THE INTEROPERABILITY GUIDELINES (IG) PROVIDED BY NYSTEC. A. PROVIDE A REPORT THAT INCLUDES A SUMMARY OF ACTIVITIES CONDUCTED BY HEALTHIX FOR THIS PHASE OF ACTIVITIES INCLUDING BUT NOT LIMITED TO NUMBER OF DATA QUALITY REPORTS COMPLETED, DESCRIPTION OF COMMUNICATION WITH HOSPITALS, MEETING MINUTES, AND FEEDBACK FROM HOSPITALS RELATED TO DATA GAPS. B. SUBMIT DATA QUALITY REPORTS FOR EACH OF THE 3 HOSPITALS, WITH DETAILS ABOUT MISSING OR REQUIRED DATA ELEMENTS IDENTIFIED DURING THE ANALYSIS. 2. SHARE WILL DATA QUALITY REPORTS WITH THE PARTICIPATING HOSPITALS. 3. HEALTHIX AND NYSTEC WILL REVIEW AND DISCUSS THE FINDINGS OF DATA ANALYSIS WITH HOSPITALS' PROJECT TEAM TO EXPLAIN THE REQUIREMENTS, DETAILS OF THE FEEDS ANALYZED, ADDRESS CONCERNS, ANSWER QUESTIONS ETC.II. VALIDATION AND DEPLOYMENT GROUP 2 HOSPITALS 1. COMPLETE SYSTEMS INTEGRATION TESTING FOR HL7 V2 ADT INTERFACE WITH IDC ESTABLISHED IN STAGE. 2. COMPLETE SYSTEMS INTEGRATION TESTING FOR HL7 V2 ORU INTERFACE WITH IDC ESTABLISHED IN STAGE. 3. VALIDATE HL7 V2 ADT REGISTRATION FEED WITH IDC IN PRODUCTION. 4. VALIDATE HL7 V2 ORU LAB FEED WITH IDC IN PRODUCTION. A. DOCUMENTATION TO DEMONSTRATE VALIDATION OF LIVE FEED AND PROCESSING ACTIVITIES (E.G. SCREENSHOTS FROM PROD ENVIRONMENT) FOR GROUP 1 HOSPITALS. B. EVIDENCE OF SIGN OFF FROM IDC THAT THE FEEDS ARE BEING RECEIVED AND MEET ALL REQUIREMENTS.III. PROJECT FINAL REPORT 1. FINAL PROJECT REPORT A. HEALTHIX WILL PRODUCE A FINAL PROJECT REPORT WHICH INCLUDES, AT MINIMUM: I. DETAILS ON VOLUME OF ADT AND ORU MESSAGES DELIVERED TO IDC, STRATIFIED BY THE 6 HOSPITALS INCLUDED IN THE PROJECT. II. GENERAL LESSONS LEARNED, BEST PRACTICES, KEY TAKEAWAYS EXPERIENCED BY HEALTHIX WITH SPECIAL FOCUS ON THE FINDINGS FROM DATA QUALITY EVALUATIONDURING THE YEAR ENDED DECEMBER 31, 2021, THE COMPANY RECORDED $154,800 IN REVENUE IN CONNECTION WITH THIS PROGRAM.2. THE COVID-19 REGISTRY PROJECTGOALTHE NEW YORK STATE DEPARTMENT OF HEALTH (NYS DOH) IS SEEKING A SYSTEM OF CAPABILITIES THAT CAN HELP THE DOH SURVEILLANCE TEAMS AND PUBLIC HEALTH RESEARCHERS BUILD PROFILES AND UNDERSTAND CLINICAL DATA ON COVID-19 PATIENTS. PROJECT DESCRIPTIONHEALTHIX LEVERAGES ITS SERVICE CALLED CLINICAL INFORMATION UPDATES (CIU) TO PROVIDE FULL LONGITUDINAL AND FOLLOW-UP UPDATE CCDA FILES TO THE DATA LAKE.HEALTHIX USES THE DAILY INCREMENTAL FILE OF COVID19 POSITIVE PATIENTS TO IDENTIFY RECORDS TO BE INCLUDED IN THE PATIENT MEMBER TABLE. FROM THIS TABLE, COVID-19 POSITIVE PATIENTS ARE ENROLLED IN THE CIU PROGRAM: COVID-19 POSITIVE. LONGITUDINAL AND UPDATE MESSAGES ARE THEN SENT FOR ALL ENROLLED PATIENTS IN THE CIU FEED TO THE DATA LAKE.HEALTHIX ALSO USES THE FULL FILE CONTAINING COVID19 ORDERS AND RESULTS TO ENROLL PATIENTS IN THE HEALTHIX COVID-19 CEN PROGRAM, WHICH ALERTS ALL HEALTHIX PARTICIPANTS OF THE DIFFERENT COVID-19 EVENTS.THE PROJECT WAS STARTED IN 2020 AND CONTINUED THROUGHOUT 2021. WE ANTICIPATE THAT THE PROGRAM WILL BE EXPANDED TO ALL PATIENTS (NOT JUST PATIENTS WHO TEST POSITIVE FOR COVID19).DURING THE YEAR ENDED DECEMBER 31, 2021, THE COMPANY RECORDED $130,022 IN REVENUE IN CONNECTION WITH THIS PROGRAM.